| Miss Barbara Andrea Herrera Rojas, SLP | |
|
14500 51st Ave Ne, Marysville, WA 98271-7503 | |
| (360) 965-8687 | |
| Not Available |
| Full Name | Miss Barbara Andrea Herrera Rojas |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 14500 51st Ave Ne, Marysville, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184474389 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 606804C (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Miss Barbara Andrea Herrera Rojas, SLP 4220 80th St Ne, Marysville, WA 98270-3498 Ph: (360) 965-0000 | Miss Barbara Andrea Herrera Rojas, SLP 14500 51st Ave Ne, Marysville, WA 98271-7503 Ph: (360) 965-8687 |
News Archive
Catapult BioAccel, formerly named CatapultBio, has announced the funding of an Arizona-based early stage firm, Kemeta LLC, a company developing a revolutionary product for application in consumer health and medical markets.
Abbott today announced results from the Phase 3 ABILITY-1 study of HUMIRA (adalimumab) in patients with active non-radiographic axial spondyloarthritis.
Meritage Pharma, Inc. announced that it has initiated a Phase 2 clinical trial to evaluate oral budesonide suspension (OBS) for the treatment of adolescents and young adults with eosinophilic esophagitis (EoE), an allergic inflammatory condition of the esophagus. EoE is a chronic disease characterized by symptoms related to esophageal dysfunction and eosinophil-predominant inflammation.
Inhibitex, Inc., announced today that it has completed enrollment in a Phase II clinical trial of FV-100 in shingles (herpes zoster) patients. The objectives of the trial are to further evaluate the safety of FV-100 and its potential therapeutic benefit in reducing the severity and duration of shingles-associated pain, the incidence of post herpetic neuralgia (PHN), and the time to heal shingles-related lesions.
› Verified 5 days ago
Deborah Bradley, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4220 80th St Ne, Marysville, WA 98270 Phone: 360-653-0896 | |
Dr. Paul Morphy, PHD CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6325 91st St Ne, Marysville, WA 98270 Phone: 360-965-1966 | |
Graham Lucas Chattin, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4220 80th St Ne, Marysville, WA 98270 Phone: 360-965-0000 | |
Marysville School District Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4220 80th Street Ne, Marysville School District, Marysville, WA 98270 Phone: 360-653-7058 Fax: 360-657-6824 | |
Maryann Walters, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4220 80th St Ne, Marysville, WA 98270 Phone: 360-653-7058 | |
Caitlin Schauer, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4407 116th St Ne, Marysville, WA 98271 Phone: 360-965-1649 |